[1]田 勇 泉.耳 鼻 咽 喉 头 颈 外 科 学[M].北 京:人 民 卫 生 出 版社,2018:215.[2]Su HX, Zhao YL. Eupatilin alleviates inflammation andepithelial-to-mesenchymal transition in chronic rhinosinusitis with nasalpolyps by upregulating TFF1 and inhibiting the Wnt/ β -cateninsignaling pathway.[J].Histology and histopathology,2023:18638.[3]Chen JC, Chen S, Gong GQ, et al. Inhibition of IL-4/STAT6/IRF4signaling reduces the epithelial-mesenchymal transition in eosinophilicchronic rhinosinusitis with nasal polyps.[J].IntImmunopharmacol,2023,121:110554.[4]Cui YZ, Qi Y, Ding L, et al. miRNA dosage control indevelopment and human disease.[J].Trends in cell biology,2023.[5]Tripti, Brar, Lisa, et al. Insights into the epigenetics of chronicrhinosinusitis with and without nasal polyps: a systematicreview.[J].Frontiers in allergy,2023,4:1165271.[6]Luan G, Wang M, Yuan J, et al. MicroRNA-21-5p promotesmucosal type 2 inflammation via regulating GLP1R/IL-33 signaling inchronic rhinosinusitis with nasal polyps.[J].J Allergy ClinImmunol,2022,150:1460-1475.[7]Huang WQ, Huang ZZ, Lai XP, et al. [The expression profile andpotential regulatory mechanism of ACE2 in chronic rhinosinusitis withnasal polyps].[J].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke ZaZhi,2022,57:692-698.[8]Al-Imam Mokhtar Jawad, Hussein Uday Abdul-Reda, SeadFadhil Faez, et al. The interactions between DNA methylation machineryand long non-coding RNAs in tumor progression and drugresistance.[J].DNA Repair (Amst),2023,128:103526.[9]Wang XP, Zhu XY, Peng L, et al. Identification of lncRNABiomarkers and LINC01198 Promotes Progression of ChronicRhinosinusitis with Nasal Polyps through Sponge miR-6776-5p.[J].Biomed Res Int,2022,2022:9469207.[10]Wang M, Bu XT, Luan G, et al. Distinct type 2-highinflammation associated molecular signatures of chronic rhinosinusitiswith nasal polyps with comorbid asthma.[J].Clin Transl Allergy,2020,10:26.[11]Liu ML,Guo P,An J,et al. Genome‑wide profiling of lncRNA andmRNA expression in CRSwNP.[J].Mol Med Rep,2019,19:3855-3863.[12]Wang WQ, Gao ZQ, Wang HS, et al. Transcriptome AnalysisReveals Distinct Gene Expression Profiles in Eosinophilic andNoneosinophilic Chronic Rhinosinusitis with Nasal Polyps.[J].SciRep,2016,6:26604.[13]Chen JC, Xing QL, Yang HW, et al. Construction and analysis ofa ceRNA network and patterns of immune infiltration in chronicrhinosinusitis with nasal polyps: based on data mining and experimentalverification.[J].Sci Rep,2022,12:9735.[14]Li K, Liu FF. Analysis of competing endogenous RNA (ceRNA)crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps.[J].IntForum Allergy Rhinol,2022,12:1468-1479.[15]Zhou XC, Zhen XY, Liu YQ, et al. Identification of Key Modules,Hub Genes, and Noncoding RNAs in Chronic Rhinosinusitis with NasalPolyps by Weighted Gene Coexpression Network Analysis.[J].Biomed ResInt,2020,2020:6140728.[16]Zhang Y, Qi J, Yan DQ, et al. HNE Induces theHyperexpression of MUC5AC in Chronic Rhinosinusitis With NasalPolyps by Activating the TRAF6/Autophagy Regulatory Axis.[J].Am JRhinol Allergy,2022,36:816-826.[17]Wang C, Zhou ML, Liu YC, et al. The Roles of Autophagy,Mitophagy, and the Akt/mTOR Pathway in the Pathogenesis of ChronicRhinosinusitis with Nasal Polyps.[J].J Immunol Res, 2022,2022:2273121
